Central Glucocorticoid Administration Promotes Weight Gain and Increased 11β-Hydroxysteroid Dehydrogenase Type 1 Expression in White Adipose Tissue

Effects of antisense-mediated inhibition of 11β-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism

(2011) Guoping Li et al.   JOURNAL OF LIPID RESEARCH

A novel genetically-obese rat model with elevated 11beta-hydroxysteroid dehydrogenase type 1 activity in subcutaneous adipose tissue

(2010) Sakamuri SS Vara Prasad et al.   Lipids in Health and Disease

Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation

(2009) Sebastian Beck Jørgensen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Resistin acutely impairs insulin-stimulated glucose transport in rodent muscle in the presence, but not absence, of palmitate

(2009) Kathryn A. Junkin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11 -Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5 -Reductase Activity

(2008) J. W. Tomlinson et al.   DIABETES

Insulin and Dexamethasone Dynamically Regulate Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1

(2008) Aran Balachandran et al.   ENDOCRINOLOGY

Glucocorticoid Regulation of the Promoter of 11β-Hydroxysteroid Dehydrogenase Type 1 Is Indirect and Requires CCAAT/Enhancer-Binding Protein-β

(2008) Shuji Sai et al.   MOLECULAR ENDOCRINOLOGY

Depot-specific Regulation of the Conversion of Cortisone to Cortisol in Human Adipose Tissue

(2008) Mi-Jeong Lee et al.   Obesity

DHEA Induces 11 -HSD2 by Acting on CCAAT/Enhancer-Binding Proteins

(2007) Z. Balazs et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY